170 related articles for article (PubMed ID: 25275664)
1. Analyzing simultaneous positive expression of EZH2 and P53 protein to improve predictive value in cervical squamous cell carcinoma.
Chen SQ; Zhang HM; Li JB; Jiang HY; Fan L; Kong LZ; Yao SZ
Int J Gynecol Cancer; 2014 Nov; 24(9):1653-8. PubMed ID: 25275664
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of expression of enhancer of zeste homolog 2 and 53 in cervical squamous cell carcinoma and intraepithelial neoplasia].
Zhang H; Chen S; Niu G; Jiang H; Yao S
Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):597-601. PubMed ID: 25430026
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.
Shiogama S; Yoshiba S; Soga D; Motohashi H; Shintani S
Anticancer Res; 2013 Oct; 33(10):4309-17. PubMed ID: 24122997
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix.
Zhang HM; Chen SQ; Yao SZ
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323178
[TBL] [Abstract][Full Text] [Related]
6. Increased EZH2 expression is associated with proliferation and progression of cervical cancer and indicates a poor prognosis.
Liu Y; Liu T; Bao X; He M; Li L; Yang X
Int J Gynecol Pathol; 2014 May; 33(3):218-24. PubMed ID: 24681730
[TBL] [Abstract][Full Text] [Related]
7. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
Cai S; Han K
J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of p53 expression in early stage cervical carcinoma treated by surgery.
Khunamornpong S; Siriaunkgul S; Manusirivithaya S; Settakorn J; Srisomboon J; Ponjaroen J; Thorner PS
Asian Pac J Cancer Prev; 2008; 9(1):48-52. PubMed ID: 18439073
[TBL] [Abstract][Full Text] [Related]
9. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
Wang H; Wang M; Lian G; Wu D
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):99-102. PubMed ID: 23353165
[TBL] [Abstract][Full Text] [Related]
10. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
Wang HR; Wang MH; Lian GY; Wu DG
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):99-102. PubMed ID: 25613619
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of Bmi1 and EZH2 as an independent poor prognostic factor in esophageal squamous cell carcinoma.
Ha SY; Kim SH
Pathol Res Pract; 2012 Aug; 208(8):462-9. PubMed ID: 22766604
[TBL] [Abstract][Full Text] [Related]
12. EZH2 overexpression in head and neck cancer is related to lymph node metastasis.
Nienstedt JC; Schroeder C; Clauditz T; Simon R; Sauter G; Muenscher A; Blessmann M; Hanken H; Pflug C
J Oral Pathol Med; 2018 Mar; 47(3):240-245. PubMed ID: 29285811
[TBL] [Abstract][Full Text] [Related]
13. p53 in surgically treated and pathologically staged cervical cancer: correlation with local tumor progression, but not with lymphatic spread.
Horn LC; Fischer U; Hänel C; Kuhn H; Raptis G; Bilek K
Pathol Res Pract; 2001; 197(9):605-9. PubMed ID: 11569924
[TBL] [Abstract][Full Text] [Related]
14. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
15. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco RS; Cunha-Melo JR
Gynecol Oncol; 2004 Dec; 95(3):646-54. PubMed ID: 15581977
[TBL] [Abstract][Full Text] [Related]
17. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
[TBL] [Abstract][Full Text] [Related]
18. Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.
Xu C; Hao K; Hu H; Sheng Z; Yan J; Wang Q; Yu L
Lung Cancer; 2014 Nov; 86(2):268-73. PubMed ID: 25262426
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.
Shiohara S; Shiozawa T; Miyamoto T; Feng YZ; Kashima H; Kurai M; Suzuki A; Konishi I
Virchows Arch; 2005 Jun; 446(6):626-33. PubMed ID: 15891905
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
